Neogen Chemicals Ltd

Neogen Chemicals Ltd has received an additional ₹15 Crore as a fourth on-account payment from its insurance company for the fire incident at its Dahej SEZ facility on March 5, 2025. This brings the total on-account claim received to ₹155 Crore. The company recognized a total loss of ₹348.16 Crore (consolidated ₹362.90 Crore) and an insurance claim receivable of ₹334.60 Crore (consolidated ₹348.82 Crore). Production at the affected MPP3 facility remains temporarily suspended, with replacement plant commissioning scheduled for H1FY27. Critical specialty products are being shifted to other sites to minimize business disruption.

Neogen Chemicals Ltd has received an additional ₹15 Crore as a fourth on-account payment from its insurance company for the fire incident at its Dahej SEZ facility on March 5, 2025. This brings the total on-account claim received to ₹155 Crore. The company recognized a loss of ₹348.16 Crore (consolidated ₹362.90 Crore) and an insurance claim receivable of ₹334.60 Crore (consolidated ₹348.82 Crore). Production at the affected MPP3 plant is temporarily suspended, with replacement construction progressing for H1FY27 commissioning. Critical specialty products are being shifted to other sites to minimize business disruption.

Neogen Chemicals Ltd has announced the closure of its trading window for all designated persons and their immediate relatives, connected persons, and legitimate insiders. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's Insider Trading Policy. The trading window will be shut from July 1, 2026, until 48 hours after the declaration of the Un-Audited standalone and consolidated financial results for the quarter ended June 30, 2026. The specific date for the Board Meeting to approve these results will be communicated later. The company has also uploaded this information on its website.

Axis Mutual Fund, managed by Axis AMC, has disposed of 1.46% of its equity shares in Neogen Chemicals Limited. This sale reduces Axis MF's total holding in the company to 4.04%. The transaction, which occurred on June 02, 2026, represents a disposal of over 2% of the equity share capital since the last reporting under SEBI's SAST Regulations, 2011. The sale was conducted as part of ordinary course portfolio investments.

Axis Mutual Fund, through its various schemes, has disposed of 1.46% of the equity share capital of Neogen Chemicals Limited. This transaction reduces their holding to 4.04%. The disposal, amounting to 4,00,000 shares, was conducted in the ordinary course of investment and falls under SEBI's disclosure regulations for substantial acquisition/disposal of shares. The total equity share capital of Neogen Chemicals is valued at approximately ₹273.82 crore.

Neogen Chemicals Ltd's board approved the audited financial results (standalone and consolidated) for the quarter and financial year ended March 31, 2026. The board also recommended a final dividend of Re. 1 per equity share for FY26, subject to shareholder approval. Amendments to the insider trading code were approved, and details of outstanding qualified borrowings were disclosed. Neogen Ionics Limited, a wholly-owned subsidiary, reported changes in the project timeline and projected cost for its Dahej and Pakhajan projects.

Neogen Chemicals Ltd's board has recommended a final dividend of Re. 1 per equity share for the financial year 2025-26, subject to shareholder approval at the upcoming 37th Annual General Meeting (AGM). The record date and AGM date will be announced later. The board also approved the audited financial results for the year ended March 31, 2026, and amendments to the insider trading code. Additionally, there's a change in project timeline and cost for Neogen Ionics Limited's Dahej and Pakhajan projects.

Neogen Chemicals Ltd approved audited financial results for the year ended March 31, 2026, and recommended a final dividend of Re. 1 per equity share, subject to shareholder approval. The company also approved amendments to its insider trading code. Additionally, there's a change in project timeline and projected cost for the Dahej and Pakhajan Project of NIL, its wholly-owned subsidiary.

Neogen Chemicals Ltd's board approved audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026. The board also recommended a final dividend of Re. 1 per equity share for FY26, subject to shareholder approval. Amendments to the insider trading code were approved, and details of outstanding qualified borrowings were disclosed. Neogen Ionics Limited, a wholly-owned subsidiary, reported changes in project timelines and costs for its Dahej and Pakhajan projects.

Neogen Chemicals Ltd has scheduled a Board of Directors meeting on May 16, 2026, to consider and approve the audited financial results (standalone and consolidated) for the quarter and financial year ended March 31, 2026. The board will also consider recommending a final dividend for FY26, subject to shareholder approval. The trading window closure period, which commenced on April 1, 2026, will end 48 hours after the declaration of the audited financial results.